Janus Henderson Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Janus Henderson Group’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-88,839	Closed	-$7.5M	–	2510
2025 Q1	$7.5M	Sell	88,839 -283	-0.3%	-$25.3K	﹤0.01%	769
2024 Q4	$8.03M	Sell	89,122 -8,048	-8%	-$780K	﹤0.01%	777
2024 Q3	$9.6M	Sell	97,170 -78,123	-45%	-$7.68M	﹤0.01%	695
2024 Q2	$16.3M	Sell	175,293 -53,568	-23%	-$4.8M	0.01%	608
2024 Q1	$21.7M	Sell	228,861 -1,284	-0.6%	-$119K	0.01%	547
2023 Q4	$20.5M	Sell	230,145 -31,500	-12%	-$2.34M	0.01%	545
2023 Q3	$19.1M	Sell	261,645 -112,225	-30%	-$8.96M	0.01%	543
2023 Q2	$31.1M	Sell	373,870 -58,510	-14%	-$4.89M	0.02%	490
2023 Q1	$33M	Sell	432,380 -65,828	-13%	-$5.46M	0.02%	471
2022 Q4	$41.4M	Sell	498,208 -882	-0.2%	-$71.4K	0.03%	416
2022 Q3	$39.6M	Buy	+499,090	New	+$42.1M	0.03%	405
2015 Q4	–	Sell	-46,785	Closed	-$2.91M	–	848
2015 Q3	$2.91M	Buy	46,785 +12,903	+38%	+$1.02M	0.03%	417
2015 Q2	$2.85M	Sell	33,882 -7,686	-18%	-$598K	0.02%	444
2015 Q1	$3.13M	Buy	+41,568	New	+$2.9M	0.02%	445
2013 Q4	–	Sell	-84,684	Closed	-$3.65M	–	780
2013 Q3	$3.65M	Buy	84,684 +7,662	+10%	+$310K	0.04%	303
2013 Q2	$2.79M	Buy	+77,022	New	+$2.71M	0.03%	328

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Janus Henderson Group's XBI Position: Q2 2025 in Review

Janus Henderson Group sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2025, closing a stake of 88,839 shares — an estimated $7.5M sold.

Janus Henderson Group first reported a position in XBI in Q2 2013 and held it in 16 quarters. The position peaked at $41.4M in Q4 2022. 625 funds tracked by Wall St. Rank hold XBI as of Q2 2025.

Janus Henderson Group reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2025 after selling out during the quarter.
Janus Henderson Group sold 88,839 State Street SPDR S&P Biotech ETF shares in Q2 2025, an estimated $7.5M.
Janus Henderson Group first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and held it in 16 quarters.
Janus Henderson Group's State Street SPDR S&P Biotech ETF position peaked at $41.4M in Q4 2022.
625 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2025.

Based on Janus Henderson Group's 13F filing for Q2 2025, filed 14 Aug 2025.